Magnitude and determinants of adverse treatment outcomes among tuberculosis patients registered under Revised National Tuberculosis Control Program in a Tuberculosis Unit, Wardha, Central India: A record-based cohort study

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Study on outcome of the treatment of tuberculosis patients registered under Revised National Tuberculosis Control Programme – DOTS strategy

Background: India has the highest burden of TB in the world, an estimated 2 million cases annually. It is also estimated by the World Health Organisation (WHO) that 300,000 people die from TB each year in India. Non-adherence to treatment has been recognized as a major problem for cure of TB. [5] Aims: To study the outcome of the treatment of tuberculosis patients under Directly Observed Treatm...

متن کامل

Notification of tuberculosis cases in India: Moving ahead in Revised National Tuberculosis Control Program

Tuberculosis (TB) is currently the leading cause of death from a curable infectious disease accounting for 8.7 million new cases and 1.4 million deaths in the year 2011. From the year 2012, TB is a notifiable disease in India which means that all cases of TB diagnosed by any means has to be reported to the public health authorities. This would help policy makers to make rational decisions with ...

متن کامل

Assessment of Directly Observed Treatment in Revised National Tuberculosis Control Programme: A Study from North India

INTRODUCTION Directly observed treatment short-course (DOTS) strategy is one of the vital components of Revised National Tuberculosis Control Programme (RNTCP) came into existence in 1997. Directly observed treatment providers (DOT providers) are the grass root level link between program and clients. AIMS This study was undertaken to assess the quality of DOTS and facilities available at DOT ...

متن کامل

A STUDY OF MYCOBACTERIUM TUBERCULOSIS DRUG RESISTANCE IN PULMONARY TUBERCULOSIS

Tuberculosis remains a major public health problem in both developing and developed countries. Drug-resistant tuberculosis is an increasing health problem and serious challenge to tuberculosis (TB) control programs. Information about the susceptibility pattern of Mycobacterium tuberculosis isolates against anti-tuberculosis drugs is an important aspect to TB control. The objectives of the s...

متن کامل

Evaluation of Hepatoprotective Effect of Silymarin Among Under Treatment Tuberculosis Patients: A Randomized Clinical Trial

Hepatic toxicity is the most serious adverse effect of anti tuberculosis drugs. This study was performed to evaluate efficacy of silymarin as a hepatoprotective herbal agent. In a randomized double blind clinical trial 70 new cases of pulmonary tuberculosis were divided into two groups. The intervention group was assigned to receive silymarin and the control group received placebo. Tuberculosis...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Epidemiology and Global Health

سال: 2017

ISSN: 2210-6014

DOI: 10.1016/j.jegh.2017.02.002